A mouse model of human familial hypercholesterolemia:: Markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet

被引:166
作者
Powell-Braxton, L
Véniant, M
Latvala, RD
Hirano, KI
Won, WB
Ross, J
Dybdal, N
Zlot, CH
Young, SG
Davidson, NO
机构
[1] Genentech Inc, Cardiovasc Res, S San Francisco, CA 94080 USA
[2] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Dept Med, San Francisco, CA 94141 USA
[3] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94141 USA
[4] Univ Chicago, Dept Med, Chicago, IL 60637 USA
关键词
D O I
10.1038/nm0898-934
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the low density lipoprotein (LDL) receptor gene cause familial hypercholesterolemia, a human disease characterized by premature atherosclerosis and markedly elevated plasma levels of LDL cholesterol and apolipoprotein (apo) B100. In contrast, mice deficient for the LDL receptor (Ldlr(-/-)) have only mildly elevated LDL cholesterol levels and little atherosclerosis. This difference results from extensive editing of the hepatic apoB mRNA in the mouse, which limits apoB100 synthesis in favor of apoB48 synthesis. We have generated Ldlr(-/-) mice that cannot edit the apoB mRNA and therefore synthesize exclusively apoB100. These mice had markedly elevated LDL cholesterol and apoB100 levels and developed extensive atherosclerosis on a chow diet. This authentic model of human familiar hypercholesterolemia will provide a new tool for studying atherosclerosis.
引用
收藏
页码:934 / 938
页数:5
相关论文
共 33 条
  • [1] MACROPHAGE-SPECIFIC EXPRESSION OF HUMAN APOLIPOPROTEIN-E REDUCES ATHEROSCLEROSIS IN HYPERCHOLESTEROLEMIC APOLIPOPROTEIN E-NULL MICE
    BELLOSTA, S
    MAHLEY, RW
    SANAN, DA
    MURATA, J
    NEWLAND, DL
    TAYLOR, JM
    PITAS, RE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) : 2170 - 2179
  • [2] TRANSGENIC MOUSE MODELS OF LIPOPROTEIN METABOLISM AND ATHEROSCLEROSIS
    BRESLOW, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) : 8314 - 8318
  • [3] Brown MS, 1991, CURR OPIN LIPIDOL, V2, P65
  • [4] Davidson Nicholas O., 1995, Current Opinion in Lipidology, V6, P70, DOI 10.1097/00041433-199504000-00002
  • [5] DAVIDSON NO, 1988, J LIPID RES, V29, P1511
  • [6] DAVIDSON NO, 1995, RNA, V1, P3
  • [7] Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100
    Farese, RV
    Veniant, MM
    Cham, CM
    Flynn, LM
    Pierotti, V
    Loring, JF
    Traber, M
    Ruland, S
    Stokowski, RS
    Huszar, D
    Young, SG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (13) : 6393 - 6398
  • [8] Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages
    Fazio, S
    Babaev, VR
    Murray, AB
    Hasty, AH
    Carter, KJ
    Gleaves, LA
    Atkinson, JB
    Linton, MF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) : 4647 - 4652
  • [9] Goldstein J. L., 1995, METABOLIC MOL BASIS, P1981
  • [10] Herz Joachim, 1995, Current Opinion in Lipidology, V6, P97, DOI 10.1097/00041433-199504000-00007